NSAUA2009 - Home
 


 
 
Thomson Reuters
 

 

Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The AUA takes responsibility for the content, quality, and scientific integrity of this CME activity.

Credit Designation:  The American Urological Association designates this educational activity for a maximum of 9.5 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity. 

Overview/Statement of Need/Target Audience
Urologists need a thorough knowledge of the most recent developments and techniques in Urology to ensure the highest standards of patient care.

Learning Objectives
At the conclusion of the 2009 Annual Meeting, participants should be able to:
• Interpret and evaluate the existing evidence in favor and against prostate cancer  screening.
• Critically appraise the data on available chemoprevention therapies for prostate      cancer.
• Weigh the pros and cons of early vs. delayed androgen deprivation therapy and critically appraise the value of continuous vs. intermittent therapy.
• Critically appraise the risks and benefits of intra-vesicle therapy relative to early cystectomy for non-muscle invasive high risk bladder cancer patients.
• Gain a thorough understanding of medical management of overactive bladder.
• Obtain an update of available management options and their efficacy for  patients with chronic prostatitis.
• Review the magnitude of urologic risks associated with testosterone supplementation.
• Examine the value of available treatment regimens for erectile dysfunction, in the aging male, as well after urologic surgery.
• Reassess the central role of the urologist in the management of surgically unresectable and metastatic renal cancer. Become familiar with the existing molecules for the management of unresectable and/or metastatic renal cell carcinoma and with the common toxicities.

AUA Disclosure Policy:  As a provider accredited by the ACCME, the AUA must insure balance, independence, objectivity and scientific rigor in all its activities.

All faculty participating in an educational activity provided by the AUA are required to disclose to the audience any relevant financial relationships with any commercial interest to the provider. The intent of this disclosure is not to prevent faculty with relevant financial relationships from serving as faculty, but rather to provide members of the audience with information on which they can make their own judgments. The AUA must resolve any conflicts of interest prior to the commencement of the educational activity. It remains for the audience to determine if the faculty’s relationships may influence the educational content with regard to exposition or conclusion. When unlabeled or unapproved uses of drugs or devices are discussed, these are also indicated.

Unlabeled or Unapproved Use of Drugs or Devices:  It is the policy of the AUA to require the disclosure of all references to unlabeled or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to unlabeled or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses. 

Disclaimer:  The opinions and recommendations expressed by faculty, authors, and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.
 
Evidence Based Content:  As a provider of continuing medical education accredited by the ACCME, it is the policy of the AUA to review and certify that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias. 

Method of Participation/Instructions
This CME activity consists of a Webcast of live scientific presentations, which were recorded during the 2009 Northeastern Section Annual Meeting. To earn credit for each presentation, please view and listen to the full lecture, accompanying slide presentation, and complete the evaluation. Claim the credits you spent in the activity through AUA within 7 days of completion of the Webcast.

Estimated Time to Complete Entire Webcast Activity: 10.5 hours
Each educational activity within this Web cast may be completed individually. The estimated time required to complete each individual portion of this educational activity is listed in the CME information at the beginning of each individual portion of this activity.

Release Date
October 2009

Expiration Date
October 31, 2010

AUA Privacy Policy
The AUA is the sole owner of the information collected on this site. We will not sell, share, or rent this information to others in ways other than those outlined in this statement. Personal information provided by users will be used by the AUA to improve the site and provide a more personalized experience for the user, but information which identifies a specific individual will not be disclosed to others without the user's permission unless necessary to provide services which the user has requested.

AUA Confidentiality Statement Full Text: 

http://www.auanet.org/cme/onlineeduconf.cfm

Commercial Support Statement

Azhar, Raed None
Bolduc, Stéphane None
Brock, Gerald B. Pfizer, Eli Lilly, Coloplast, Bayer and Johnson and  Johnson: Consultant or Advisor
Chen, Mang L. None
Fitzpatrick, John M. None
Jolivet-Tremblay, Martine None
Karakiewicz, Pierre Abbot Canada: Scientific Study or Trial
Klein, Eric A. Abbott Diagnostics: Research Support; Genomic Health: Research Support
Messing, Edward None
Moldwin, Robert Ortho McNeil Pharmacuiticals: Consultant or Advisor; Pfizer:Consultant or Advisor, Investigator; Plethora: Investigator
Nickel, J. Curtis Watson Pharmaceuticals: Commercial Entity, Consultant, Investigator; Stellar: Investigator, Commercial Entity, Other
Ransley, Philip None
   
Contact Information
For all inquires regarding CME credit please contact:
Sandra Baird, BS
CME Compliance Officer
American Urological Association
1000 Corporate Blvd.
Linthicum, MD  21090
410-689-4040
sbaird@auanet.org
 
Disclaimer:  The opinions and recommendations expressed by faculty, authors, and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.